• Home
• Conference Coverage
• Event Calendar
• UroToday International Journal
• Advanced Search

Search    Display 5 10 15 20 25 30 50 results per page Results 1 - 9 of 9 << Start < Prev 1 Next > End >> European Urology - Vardenafil Duration of Action Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 901-902 (November 2006) Article Outline: The time we spend with a patient explaining how to use a phosphodiesterase type 5 inhibitor (PDE5-I) and the quality of the information we provide are recognised as important factors that contribute to the success of the treatment. read more European Urology - Nomograms and Medicine Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 884-886 (November 2006) Article Outline: Prostate cancer is the most common malignancy in European men. read more European Urology - Prosthetic Nephrovesical Bypass Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 879-883 Article Outline: Patients with advanced malignant masses in the retroperitoneum often present with renal failure due to ureteral obstruction. read more European Urology - The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 873-878 Article Outline: Geoffrey Chisholm was a far-sighted urologist and his innovation and forward-thinking is exemplified in this seminal paper. read more European Urology - Rationale for Androgens and Erectile Dysfunction in 2006 Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 898-900 (November 2006) Article Outline: Erectile function (EF) is a critical and complex neurovascular process mediated by several biochemical and physiologic factors. read more European Urology - Testosterone and Prostate Health: Debunking Myths Demands Evidence, Caution, and Good Clinical Judgment Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 895-897 (November 2006) Article Outline: The review article by Dr Morgentaler [1] on this highly controversial topic is a timely and well-thought-out challenge to urologists worldwide. read more European Urology - Surgery is an Essential Part of Salvage Treatment in Refractory Germ Cell Tumors Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 893-894 (November 2006) Article Outline: Cisplatin-refractory germ cell tumours represent an unfavourable subgroup of testis cancer patients with a less than 10% chance of long-term survival [1]. read more European Urology - Rebuttal from Authors re: Urs E. Studer, Laurence Collette. Morbidity from Pelvic Lymphadenectomy in Men Undergoing Radical Prostatectomy. Eur Urol 2006;50:887–9. Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 889-892 (November 2006) Article Outline: The extent of pelvic lymphadenectomy in men with clinically localized prostate cancer represents an area of controversy. read more European Urology - Morbidity from Pelvic Lymphadenectomy in Men Undergoing Radical Prostatectomy Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 887-889 (November 2006) Article Outline: As is true for the surgical treatment of many other cancers, there is an increasing interest in determining the value of a meticulous pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy. read more   << Start < Prev 1 Next > End >> Results 1 - 9 of 9

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2010 UroToday ® All Rights Reserved